Richard Burr: “No child should ever have to suffer the pain or shame of abuse at the hands of an adult.”

I oppose Ms. Kotagal's nomination and urge my colleagues to do the same.

I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

Without Orrin, we wouldn't have a generic drug industry.